Grants and Contributions
About this information
In June 2016, as part of the Open Government Action Plan, the Treasury Board of Canada Secretariat (TBS) committed to increasing the transparency and usefulness of grants and contribution data and subsequently launched the Guidelines on the Reporting of Grants and Contributions Awards, effective April 1, 2018.
The rules and principles governing government grants and contributions are outlined in the Treasury Board Policy on Transfer Payments. Transfer payments are transfers of money, goods, services or assets made from an appropriation to individuals, organizations or other levels of government, without the federal government directly receiving goods or services in return, but which may require the recipient to provide a report or other information subsequent to receiving payment. These expenditures are reported in the Public Accounts of Canada. The major types of transfer payments are grants, contributions and \'other transfer payments\'.
Included in this category, but not to be reported under proactive disclosure of awards, are (1) transfers to other levels of government such as Equalization payments as well as Canada Health and Social Transfer payments. (2) Grants and contributions reallocated or otherwise redistributed by the recipient to third parties; and (3) information that would normally be withheld under the Access to Information Act and the Privacy Act.
$105,000.00
May 1, 2017
Defining the roles of Wnt signalling and cilia in the pathogenesis of adolescent idiopathic scoliosis
$150,000.00
May 1, 2017
Understanding and improving wait times for hip fracture surgery in Ontario
$150,000.00
May 1, 2017
The neuromuscular function as a diagnostic tool and a therapeutic target in an ALS mouse model
$105,000.00
May 1, 2017
Supporting Opportunities for Prevention through Health Impact Assessment (SOPHIA): A Pan-Canadian Realist Review
$150,000.00
May 1, 2017
Preclinical assessment of a novel Chlamydia vaccine
$150,000.00
May 1, 2017
Examining Neighbourhood Socioeconomic Status, Anxiety during Pregnancy, and Preterm Birth
$105,000.00
May 1, 2017
Consequences, healthcare utilization and cost of autosomal dominant polycystic kidney disease
$150,000.00
May 1, 2017
Impact of provincial primary care reforms on the management of persons with Alzheimer's disease and on associated health care use and cost
$105,000.00
May 1, 2017
Novel hypermethylated tumor suppressor genes as indicators of decitabine sensitivity in breast cancer
$105,000.00
May 1, 2017
Immunotherapy against neuroserpin to correct Nerve Growth Factor metabolic dysfunction and consequent cholinergic and cognitive deficits in a transgenic rat model of Alzheimer's disease.